Feature Channels: Addiction

Filters close
Released: 1-May-2023 1:00 PM EDT
Expert calls for reforms to address the overdose crisis
Mass General Brigham

At the end of 2022, the federal government eliminated the “X waiver,” a major hurdle to providing addiction treatment, but progress needs to be continued, according to the authors of a new Perspective piece published in the New England Journal of Medicine.

Released: 27-Apr-2023 7:20 PM EDT
Sounds from nature: A soothing remedy for gambling addiction
Chiba University

Gambling addiction, also called “pathological gambling” and “gambling disorder (GD),” is known to have severe economic, social, mental, and physical consequences on those affected. One of the major factors contributing to the development and relapse of this disorder is stress.

   
Newswise: Psychology Expert: Smartphones Negatively Impact Mental Health
Released: 27-Apr-2023 5:10 PM EDT
Psychology Expert: Smartphones Negatively Impact Mental Health
New York Institute of Technology, New York Tech

New York Institute of Technology psychology researchers finds evidence that smartphones increase anxiety and erode mindfulness and comprehension.

   
Released: 25-Apr-2023 12:05 PM EDT
Study: Treatment for opioid addiction lags despite policies designed to increase it
Michigan Medicine - University of Michigan

Treating opioid addiction should be much easier now than it was a few years ago, thanks to pandemic-era rule changes that aim to improve access to buprenorphine, a medicine proven to help in recovery. But a new study shows prescriptions and adherence rates have remained flat.

Released: 25-Apr-2023 12:05 PM EDT
Junk food ads trigger positive emotions, healthy foods not so much
University of Michigan

You might not care about the fast-food commercial shots of juicy burgers or creamy milkshakes, but they might change your beliefs about these items, whereas shots of fresh salads and berries might not, according to a new study.

Released: 24-Apr-2023 6:05 PM EDT
UCLA Health seeks participants for first-of-its-kind study using injectable buprenorphine to treat methamphetamine use disorder and opioid co-use
University of California, Los Angeles (UCLA), Health Sciences

UCLA Health investigators are leading a new, six-city trial of injectable buprenorphine for treatment of methamphetamine use disorder in adults who also use opioids.

Newswise:Video Embedded live-event-for-april-21-sleeping-pill-reduces-levels-of-alzheimer-s-proteins
VIDEO
Released: 21-Apr-2023 3:10 PM EDT
TRANSCRIPT AND VIDEO AVAILABLE Live Event for April 21: Sleeping pill reduces levels of Alzheimer’s proteins
Newswise

Researcher will discuss the study which involved a sleeping aid known as suvorexant that is already approved by the Food and Drug Administration (FDA) for insomnia, hints at the potential of sleep medications to slow or stop the progression of Alzheimer’s disease.

       
14-Apr-2023 11:00 AM EDT
In some US schools, 1 in 4 students report misusing prescription stimulants
University of Michigan

U.S. middle and high schools with the most students taking prescription stimulants to treat ADHD also had, overall, the highest percentage of students who misused prescription stimulants within the past year.

Released: 14-Apr-2023 7:40 PM EDT
Offering medications for opioid addiction to incarcerated individuals leads to decrease in overdose deaths
Boston Medical Center

New research from Boston Medical Center concluded that offering medications to treat opioid addiction in jails and prisons leads to a decrease in overdose deaths. Published in JAMA Network Open, the study also found that treating opioid addiction during incarceration is cost-effective in terms of healthcare costs, incarceration costs, and deaths avoided.

Released: 14-Apr-2023 1:05 PM EDT
How AI and a mobile phone app could help you quit smoking
University of East Anglia

A stop smoking mobile app that senses where and when you might be triggered to light up could help people quit – according to University of East Anglia research.

   
Newswise: The brain’s cannabinoid system protects against addiction following childhood maltreatment
Released: 12-Apr-2023 1:30 PM EDT
The brain’s cannabinoid system protects against addiction following childhood maltreatment
Linkoping University

High levels of the body’s own cannabinoid substances protect against developing addiction in individuals previously exposed to childhood maltreatment, according to a new study from Linköping University in Sweden.

Released: 12-Apr-2023 12:15 PM EDT
Millions with opioid addiction don't receive residential treatment
Northwestern University

First study to do apples-to-apples comparison of residential treatment use among Medicaid enrollees across several states

12-Apr-2023 10:05 AM EDT
Open-label placebo improved outcomes for people in treatment for opioid use disorder
Beth Israel Deaconess Medical Center

Researchers tested whether using open-label placebo could increase the efficacy of methadone treatment for people undergoing care for opioid use disorder.

Newswise: Education and peer support cut binge-drinking by National Guard members in half, study shows
Released: 12-Apr-2023 12:05 AM EDT
Education and peer support cut binge-drinking by National Guard members in half, study shows
Michigan Medicine - University of Michigan

A new study shows promise for reducing risky drinking among Army National Guard members over the long term, potentially improving their health and readiness to serve. The number of days each month that Guard members said they had been binge-drinking dropped by up to half over the course of a year of either online only education or online and peer-based support.

   
Newswise: IU researchers receive $8.6M NIH grant renewal to study alcohol use, binge drinking
Released: 5-Apr-2023 2:20 PM EDT
IU researchers receive $8.6M NIH grant renewal to study alcohol use, binge drinking
Indiana University

A multi-disciplinary team of Indiana University researchers is focusing their efforts on a growing public health concern: binge and “high-intensity” drinking—extreme drinking behaviors that are increasingly prevalent among college-age adults.

Released: 4-Apr-2023 3:25 PM EDT
NIH Awards $8 Million to Wake Forest University School of Medicine’s Translational Alcohol Research Center
Wake Forest University School of Medicine

The National Institute on Alcohol Abuse and Alcoholism (NIAAA), part of the National Institutes of Health (NIH), has awarded Wake Forest University School of Medicine a renewal grant of $8 million over five years for research on alcohol use disorder. With the support of the grant, the Wake Forest Translational Alcohol Research Center will build upon a highly productive translational alcohol research program that was established with prior support from the NIH.

Released: 4-Apr-2023 1:35 PM EDT
Cocaine damage routinely misdiagnosed as nonthreatening nasal disease
Oxford University Press

A new paper in Rheumatology Advances in Practice, published by Oxford University Press, indicates that Granulomatosis With Polyangiitis, a nasal disease that causes inflammation of the blood vessels and commonly presents with symptoms in sinuses, throat, lungs, and kidneys, may be commonly misdiagnosed.

Released: 3-Apr-2023 12:05 PM EDT
E-health reduces patient pain, opioids in clinical study
Washington State University

An online “e-health” program helped more people with chronic pain reduce their opioid medications and pain intensity than a control group that had only regular treatment in a recent clinical study.

Released: 29-Mar-2023 1:00 PM EDT
‘UC Quits’ project helps patients stop smoking
UC Davis Health

A new study, the first collaboration of its kind by all five University of California health systems, shows UC Quits helps patients stop smoking.

Released: 29-Mar-2023 9:50 AM EDT
FDA’s approval of over-the-counter naloxone will save lives
American Society of Anesthesiologists (ASA)

The American Society of Anesthesiologists (ASA) urges the public to help fight the opioid epidemic by learning to recognize and respond to an overdose. This includes understanding how to use naloxone, a life-saving medication approved today for sale over the counter by the U.S. Food and Drug Administration.

Released: 28-Mar-2023 2:20 PM EDT
From the doctor's office to the operating room: Keep up with the latest in healthcare here
Newswise

From septic shock to sticker shock. Keep up with this ever-growing, changing sector. Below are some of the latest stories on healthcare on Newswise.

Newswise: Fibromyalgia may worsen opioid addiction, study finds
Released: 28-Mar-2023 12:35 PM EDT
Fibromyalgia may worsen opioid addiction, study finds
Ohio State University Wexner Medical Center

There is new evidence that fibromyalgia, and the chronic pain associated with it, could worsen opioid use disorder. Researchers at The Ohio State University Wexner Medical Center, College of Medicine and University of Michigan report their findings in the journal PAIN.

Newswise: Legal cannabis markets linked to increased motor vehicle deaths
Released: 27-Mar-2023 10:05 AM EDT
Legal cannabis markets linked to increased motor vehicle deaths
University of Illinois Chicago

Researchers found recreational cannabis markets were associated with a 10% increase, on average, in motor vehicle accident deaths.  The study was conducted using death certificate data to compare mortality rates in states that legalized recreational cannabis dispensaries with states that only provided access to medical cannabis.

Newswise: Where there’s smoke, there’s thiocyanate: McMaster researchers find tobacco users in Canada are exposed to higher levels of cyanide than other regions
Released: 24-Mar-2023 11:30 PM EDT
Where there’s smoke, there’s thiocyanate: McMaster researchers find tobacco users in Canada are exposed to higher levels of cyanide than other regions
McMaster University

Tobacco users in Canada are exposed to higher levels of cyanide than smokers in lower-income nations, according to a large-scale population health study from McMaster University.

Newswise: NIH Awards Researchers $7.5 Million to Create Data Support Center for Opioid Use Disorder and Pain Management Research
Released: 24-Mar-2023 11:20 AM EDT
NIH Awards Researchers $7.5 Million to Create Data Support Center for Opioid Use Disorder and Pain Management Research
Wake Forest University School of Medicine

Researchers at Wake Forest University School of Medicine have been awarded a five-year, $7.5 million grant from the National Institutes of Health (NIH) Helping End Addiction Long-term (HEAL) initiative. The NIH HEAL initiative, which launched in 2018, was created to find scientific solutions to stem the national opioid and pain public health crises.

20-Mar-2023 1:20 PM EDT
Multiple substance use disorders may share inherited genetic signature
Washington University in St. Louis

New research led by Washington University School of Medicine in St. Louis identifies a common genetic signature that may increase a person's risk of developing substance use disorders. The work eventually could lead to universal therapies to treat multiple substance use disorders and potentially help people diagnosed with more than one.

Released: 17-Mar-2023 5:20 PM EDT
Inmates With Opioid Addiction Report Peer Navigators Are Crucial for Successful Community Reentry
Rutgers University-New Brunswick

Recently incarcerated people with opioid use disorder have trust in working with peer support specialists who recovered from addiction and faced similar life experiences, according to a Rutgers study.

Newswise: How the COVID-19 Pandemic Intensified the Ongoing Opioid Crisis
Released: 17-Mar-2023 9:00 AM EDT
How the COVID-19 Pandemic Intensified the Ongoing Opioid Crisis
California State University, Fullerton

Anthony DiStefano, professor of public health at Cal State Fullerton, believes that the sudden social isolation that occurred during the COVID-19 pandemic had an influence on mental health and drug overdose deaths.

Released: 15-Mar-2023 3:45 PM EDT
Don't keep hitting that snooze button! Get the latest research news and expert commentary on sleep here.
Newswise

It's sleep awareness week, according to the National Sleep Foundation. It’s important to understand how sleep deprivation can impact your health. Most people recognize that if they don’t get enough sleep, their mood and memory will suffer the next day.

       
Released: 15-Mar-2023 12:45 PM EDT
Comparison with Canada highlights poor access to US methadone treatment
Washington State University

People living in the United States must travel significantly farther to access methadone treatment for opioid addiction than Canadians, suggests a new study led by Washington State University researchers.

Released: 10-Mar-2023 11:05 AM EST
New Jersey Health Data Project Approves Research to Address Population Health Needs
Rutgers University-New Brunswick

The governing board of the New Jersey Integrated Population Health Data (iPHD) project approved pilot funding and the release of data for four research proposals in its inaugural application cycle. The project builds on the working relationship between Rutgers University and state agencies to further population health research by linking administrative data.

Newswise:Video Embedded fentanyl-the-new-talk-between-parents-and-teens
VIDEO
Released: 8-Mar-2023 11:05 AM EST
Fentanyl: The New Talk Between Parents and Teens
Cedars-Sinai

Parents have a new—and deadly—reason to sit down with their tweens and teens for a talk about drug abuse. The reason: fentanyl.

Released: 6-Mar-2023 7:50 PM EST
Preteens with problematic social media use more likely to hold positive beliefs about alcohol
University of Toronto

A new national study published in BMC Public Health suggests that problematic social media use in early adolescents is associated with both positive and negative alcohol beliefs, which play a key role in predicting alcohol use and, potentially, the development of alcohol use disorder later in life.

Released: 28-Feb-2023 1:45 PM EST
Adult Smokers With Mental Illness Consume the Most Caffeine in the U.S.
Rutgers University-New Brunswick

Americans are drinking more caffeinated beverages than ever before, but Rutgers researchers found one group that tops the charts in caffeine consumption: adult smokers with mental illness.

Released: 21-Feb-2023 2:05 PM EST
A New Catalyst For Recycling Plastic, New Antioxidants Found In Meat, And Other Chemical Research News
Newswise

Below are some of the latest articles that have been added to the Chemistry news channel on Newswise.

Newswise: New study reveals ketamine could be effective treatment for cocaine-use disorders
Released: 20-Feb-2023 10:40 AM EST
New study reveals ketamine could be effective treatment for cocaine-use disorders
Case Western Reserve University

As cocaine use continues to climb across the United States, scientists have struggled to develop an effective pharmacological approach to treat the devastating disorder. But by seamlessly combining artificial intelligence (AI), human intelligence, clinical testing and computer analysis, researchers at Case Western Reserve University have unearthed an existing option that appears to hold promise.

Newswise: Study finds 'staggering increase' in methamphetamine deaths tied to opioid co-use
Released: 20-Feb-2023 10:30 AM EST
Study finds 'staggering increase' in methamphetamine deaths tied to opioid co-use
University of Illinois Urbana-Champaign

The U.S. methamphetamine mortality rate increased fiftyfold between 1999 and 2021, with most of the added deaths also involving heroin or fentanyl, researchers report in the American Journal of Public Health.

Newswise: How AI Can Help Design Drugs to Treat Opioid Addiction
13-Feb-2023 1:45 PM EST
How AI Can Help Design Drugs to Treat Opioid Addiction
Biophysical Society

ROCKVILLE, MD – Approximately three million Americans suffer from opioid use disorder, and every year more than 80,000 Americans die from overdoses. Opioid drugs, such as heroin, fentanyl, oxycodone and morphine, activate opioid receptors. Activating mu-opioid receptors leads to pain relief and euphoria, but also physical dependence and decreased breathing, the latter leading to death in the case of drug overdose.

   
Released: 15-Feb-2023 10:55 AM EST
American Society of Anesthesiologists Express Strong Support for Over-the-Counter Naloxone Use
American Society of Anesthesiologists (ASA)

In a letter to the U.S. Food and Drug Administration (FDA), the American Society of Anesthesiologists (ASA) expressed its strong support of naloxone nasal spray products for non-prescription use. Naloxone, a safe life-saving medication that rapidly reverses an opioid overdose and significantly reduces the incidence of opioid overdose deaths, should be available to all patients across the United States as a nonprescription treatment, according to the ASA.

Released: 14-Feb-2023 11:20 AM EST
Decaf kills coffee withdrawal symptoms
University of Sydney

Coffee drinkers can take advantage of a new placebo discovery showing decaffeinated coffee quenches withdrawal symptoms in people reliant on their daily caffeine fix.

Released: 14-Feb-2023 11:15 AM EST
Cocaine addiction makes the brain age faster, suggests study
Frontiers

A new study finds evidence from the DNA methylome that the biological age – different from the chronological age – of cells in Brodmann Area 9 of the prefrontal cortex might be greater in people with cocaine use disorder. This suggests that cocaine abuse makes these cells age faster according to the ‘epigenetic clock’. The authors also find differences in methylation in 20 genes, mainly involved in regulation of the activity of neurons and their connectivity. This post-mortem study is one of the first to directly look at the methylome of brain cells in human donors with cocaine use disorder, rather than in rodents.

Newswise: Cocaine Use Disorder Alters Gene Networks of Neuroinflammation and Neurotransmission in Humans
6-Feb-2023 3:50 PM EST
Cocaine Use Disorder Alters Gene Networks of Neuroinflammation and Neurotransmission in Humans
Mount Sinai Health System

Analysis reveals similar changes in the brain’s functioning in both humans and mouse models

6-Feb-2023 11:00 AM EST
Cannabis has same effect on adolescents and adults, and CBD doesn’t dampen effects
University College London

The short-term effects of vaporised cannabis do not differ between adolescents and adults, while cannabidiol (CBD) does not dampen the effects of the drug, finds a new study led by UCL and King’s College London researchers.



close
1.70577